Home › Mylan targets Perrigo shareholders in latest generics mega-merger attempt
 

Keywords :   


Mylan targets Perrigo shareholders in latest generics mega-merger attempt

2015-09-14 23:16:14| Biotech - Topix.net

Mylan has been looking to acquire generics and OTC drugmaker Perrigo since it launched a hostile bid in April . Last week Mylan said in a letter "shareholders will receive $75 per share in cash, and own approximately 40% of the new powerhouse company created by the combination," and today has formalised this offer, which values Perrigo at just over $27bn .

Tags: latest attempt targets shareholders

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
More »